| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Department of Medical Microbiology, Clinical Virology Laboratory, McGill University Health Centre, Montreal, Quebec, Canada,1 Laboratoire de Santé Publique du Québec/Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Quebec, Canada2
Received 3 August 2007/ Returned for modification 29 January 2008/ Accepted 12 March 2008
The performance of a commercially manufactured direct fluorescent-antibody assay kit for human metapneumovirus was compared to that of reverse transcriptase PCR, the current "gold standard." The kit demonstrated a sensitivity of 95.2%, a specificity of 100%, and an accuracy of 98.9%.
Published ahead of print on 26 March 2008.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|